Cite

HARVARD Citation

    Gien, L. et al. (n.d.). Phase II study of sunitinib in tumors with c-KIT mutations: results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol V. European journal of cancer. pp. S86-. [Online]. 
  
Back to record